Here's one:
http://www.ncbi.nlm.nih.gov/sites/e...ailView&TermToSearch=8929262&ordinalpos=1&ito
And if you consider recent evidence that the more narcotics you give during surgery the more pain the pts experiences post-op and therefore the more narcs they need post-op. Which means more tachycardia and hypertension which "may" lead to more cardiac events.
Now if you believe that the intraop beta blocker can decrease post-op pain then it may also benefit the pt in terms of cardiac status. I know, It hasn't been proven but it makes sense now doesn't it.
Just something to think about.
My question about metoprolol vs fentanyl was mostly rhetorical. I'm not arguing that beta blockers are a bad thing. I'm merely pointing out that there is not really any evidence that an intraoperative dose of beta blocker has any positive outcome effects and that some so called experts feel that the things we normally do to avoid hypertension and tachycardia provide the same benefit as beta blockers.
I also wouldn't quote the Mangano atenolol study for much of anything. There are much, much better perioperative beta blocker studies out there. Some good, some bad.
Some of the bad (I don't have links)
-PJ Devereaux in 2005 had a metanalysis covering 22 RCTs and 2437 patients undergoing noncardiac surgery. There was no significant benefit to beta blockers, but a significant increase in bradycardia and hypotension requiring treatment. That was no benefit in mortality, no benefit in cardiac mortality, no benefit in nonfatal MI, no benefit in nonfatal cardiac arrest, no benefit in stroke, etc.
-Yang in 2004 looked at Metoprolol after vascular surgery RCT of metop vs placebo in 497 patients. Pretty high risk patients and they had no difference in any outcome.
-Juul in 2006 had an RCT of 921 patients with diabetes undergoing major noncardiac surgery randomized to toprol xl vs placebo started preop and continued through discharge. Once again found no significant difference in any outcome.
Now don't get me wrong. There have been some decently done smaller trials that have also shown some evidence for improved outcomes with "perioperative beta blockade". But perioperative can mean anything from started 30 days preop to started on the day of surgery and it is equally as variable as to how long in duration.
There just isn't a good answer right now, though. The largest trials tend to show no benefit and some harm while enough smaller trials show benefits to make you wonder. The POISE trial is attempting to enroll 10,000 patients randomized to metoprolol vs placebo for 3 weeks with 30 day and 1 year followup. It will have a lot more power than any of the other RCTs and actually might shed some more light on the subject.
But anybody that claims to know the answer right now is full of something.